Chest wall irradiation does not impact 10-year survival in intermediate-risk breast cancer

Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the BIG 2-04 MRC SUPREMO clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.

Smith+Nephew and HOPCo Partner to Enhance Musculoskeletal Care

What You Should Know: – Smith+Nephew, a global leader in medical technology, has announced a strategic partnership with Healthcare Outcomes Performance Company (HOPCo), the world’s

July 31, 2024

Quick Albuminuria Reduction Key Factor in Finerenone’s Efficacy

Early albuminuria reduction with finerenone (Kerendia) drove protection against chronic kidney disease (CKD) progression in people with type 2 diabetes, according to a post-hoc mediation

December 6, 2023

Bristol Myers invests $35M into Immatics; FibroGen names new CEO

Bristol Myers Squib has made a $35 million investment into the T cell-focused biotech Immatics, purchasing over 2.4 million shares. The move will allow for

July 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.